Stewart Abbot

Chief Development Officer, Fate Therapeutics.

Companies

Turnstone Biologics Corp.Chief Scientific Officer Jul 20, 2023 to Oct 17, 2023¹
Adicet Bio, Inc.Officer Sep 17, 2020 to Jun 14, 2021²
Fate TherapeuticsChief Development Officer Oct 16, 2015 to May 16, 2018³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARTurnstone Biologics Corp., Chief Scientific Officer
2
SEC EDGARAdicet Bio, Inc., Officer
3
SEC EDGARFate Therapeutics, Chief Development Officer